Insider Transactions
Date | Filing | Filer | Title | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
May 03, 2023 | Form 4 |
Director
Trans History: 71
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,096 | -- | 3,992 |
May 03, 2023 | Form 4 |
Director
Trans History: 10
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,096 | -- | 5,992 |
Dec 14, 2004 | Form 4 |
Director, Chief Financial Officer
Trans History: 282
|
Director, Chief Financial Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,097 | -- | 2,097 |
Feb 14, 2007 | Form 4 |
Director, Chief Financial Officer
Trans History: 282
|
Director, Chief Financial Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,098 | -- | 259,904 |
Feb 13, 2007 | Form 4 |
Director, Chairman and CEO
Trans History: 1071
|
Director, Chairman and CEO | Open market or private sale of non-derivative or derivative security | 2,100 | $88.25 | 550,905 |
Nov 10, 2021 | Form 4 |
Director
Trans History: 107
|
Director | Open market or private sale of non-derivative or derivative security | 2,105 | $73.78 | 48,464 |
Mar 19, 2004 | Form 4 |
Chief Financial Officer
Trans History: 282
|
Chief Financial Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,122 | -- | 2,122 |
Sep 05, 2012 | Form 4 |
Managing Director
Trans History: 121
|
Managing Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,131 | -- | 17,345 |
Jul 20, 2004 | Form 4 |
Director, Chairman and CEO
Trans History: 1071
|
Director, Chairman and CEO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 2,136 | -- | -- |
Mar 08, 2019 | Form 4 |
Trans History: 57
|
Open market or private sale of non-derivative or derivative security | 2,150 | $63.98 | 17,976 |
Data provided by Kaleidoscope.
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.